Your browser doesn't support javascript.
loading
Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells.
Ferreira, Tiago; Kulkarni, Amit; Bretscher, Clemens; Nazarov, Petr V; Hossain, Jubayer A; Ystaas, Lars A R; Miletic, Hrvoje; Röth, Ralph; Niesler, Beate; Marchini, Antonio.
Afiliação
  • Ferreira T; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Centre, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Kulkarni A; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg.
  • Bretscher C; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Centre, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
  • Nazarov PV; Bioinformatics Platform and Multiomics Data Science Research Group, Department of Cancer Research, Luxembourg Institute of Health, L-1526 Luxembourg, Luxembourg.
  • Hossain JA; Department of Biomedicine, University of Bergen, 5007 Bergen, Norway.
  • Ystaas LAR; Department of Biomedicine, University of Bergen, 5007 Bergen, Norway.
  • Miletic H; Department of Biomedicine, University of Bergen, 5007 Bergen, Norway.
  • Röth R; Department of Pathology, Haukeland University Hospital, 5021 Bergen, Norway.
  • Niesler B; nCounter Core Facility, Institute of Human Genetics, University of Heidelberg, 69120 Heidelberg, Germany.
  • Marchini A; Department of Human Molecular Genetics, University of Heidelberg, 69120 Heidelberg, Germany.
Viruses ; 14(5)2022 05 11.
Article em En | MEDLINE | ID: mdl-35632759

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Galectina 1 / Vírus Oncolíticos / Terapia Viral Oncolítica / Parvovirus H-1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Galectina 1 / Vírus Oncolíticos / Terapia Viral Oncolítica / Parvovirus H-1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article